What if there were an effective way to evaluate upfront which patients are the most likely to complete a clinical trial?
- Recruiting for clinical trials would be easier and less expensive
- The overall cost of clinical trials would be significantly reduced
- Product development time would be shortened and products would be brought to market faster
EnrichMap has built upon years of medical and population research to create the EMap Profile to assess the likelihood of compliance in clinical trials.
The EMap Profile is administered online (or with a paper version) and takes less than 10 minutes to complete. Patients are categorized into one of six segmentation groups based upon their likelihood of compliance with medical and healthcare protocols and their likelihood of completing a clinical trial.
EnrichMap is conducting further validation research before the program is introduced to the general healthcare market. and is seeking healthcare organizations to participate in this final phase of research.
EnrichMap will work with participating organizations to administer the EMap Profile to their clinical trial patients and analyze their compliance results to confirm efficacy.
After this final research has been completed, healthcare organizations who participate will be able to purchase or license the EMap Profile at a significantly discounted rate to acknowledge their assistance.
To participate or for more information please call: Enhanced Screening Solutions at (866) 784-2323
